Skip to main content

Table 1 The intermission of RT and days of RT without carboplatin

From: Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapy

Days

Intermission days of RT n (%)

Days of RT without carboplatin n (%)

0

37 (54)

27 (39)

1–5

8 (12)

13 (19)

6–10

12 (7)

13 (19)

11–20

11 (16)

13 (19)

21–

1 (1)

3 (4)